May

Shifting the spending in human capital to the young in British Columbia

Conceptually, harm reduction is an approach that reduces the harmful effects of behavior. It involves a range of nonjudgmental approaches and strategies aimed at providing and enhancing the knowledge, skills, resources, and supports for individuals, their families, and communities to make informed decisions to be safer and healthier.[1]

In contemporary medicine, the clinician must be able to readily incorporate information from clinical trials into his or her busy clinical practice. This process is made easier when the information is derived from rigorously conducted, large-scale, randomized clinical trials with meaningful endpoints (such as trials that show a reduction in mortality from a particular intervention). However, in modern clinical trials, measuring these endpoints may be difficult or impossible. This limitation is especially true in the study of atherosclerosis.

In the field of infectious disease, cholera is one of the most instructive diseases to study because it touches on several disciplines, in­cluding microbiology, epidemiology, marine biology, climatology, waste management, and socioeconomics. The study of cholera began in earnest more than 100 years ago. In 1854, the city of London was in the grip of a terrible cholera outbreak affecting hundreds and killing dozens.

Polycystic ovary syndrome (PCOS) is a prevalent reproductive and metabolic disorder with variable phenotypes and an underlying pathophysiology that is still not completely understood.